© 2022 KGOU
KGOU_Header_72dpi-01_0.jpg
News and Music for Oklahoma
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Resources and links to information about the novel coronavirus COVID-19Oklahoma State Department of Health's Vaccination Portal: https://vaccinate.oklahoma.govOklahoma State Department of Health - Color-coded COVID-19 Alert System (Map)Oklahoma State Department of Health - COVID-19 OutbreakWhat to do if you are sickHotline: (877) 215-8336 or dial 211Integris Health symptom checkerOklahoma City/County Health Dept. Hotline for the Uninsured or those without a primacy care physician: (405) 425-4489Data Source: Acute Disease Service, Oklahoma State Department of Health.00000178-7581-ddab-a97a-7fb96f110000OU Medicine - COVID-19The Regional Food Bank of Oklahoma encourages anyone needing food assistance to visit rfbo.org/get-help or call (405) 972-1111University of Oklahoma Coronavirus Resources

Canada Authorizes Use Of Pfizer COVID-19 Vaccine

A nurse in the U.K. prepares to administer COVID-19 vaccinations this week. Canadian health officials on Wednesday authorized the use of the Pfizer-BioNTech vaccine.
Hugh Hastings
/
Getty Images
A nurse in the U.K. prepares to administer COVID-19 vaccinations this week. Canadian health officials on Wednesday authorized the use of the Pfizer-BioNTech vaccine.

Canadian health officials have authorized use of the country's first COVID-19 vaccine. Health Canada announced the move Wednesday, saying a "thorough, independent review of the evidence" determined that the vaccine produced by Pfizer and BioNTech meets the "stringent safety, efficacy and quality requirements for use in Canada."

The move makes Canada just the third country to authorize the Pfizer-BioNTech vaccine for general use after the U.K. greenlighted it last week and began widely administering immunizations on Tuesday. Bahrain also granted an emergency use authorization to the vaccine last week.

In the U.S., meanwhile, emergency authorization of the vaccine could come within days. In an analysis released Tuesday, the Food and Drug Administration affirmed the vaccine's safety and its 95% effectiveness at preventing the coronavirus.

An FDA advisory panel meeting Thursday is expected to support emergency use of the vaccine in the United States. Then a final authorization decision will be up to agency officials.

It's important to note that in Canada, as in the U.K. — and likely soon in the U.S. — regulators are only authorizing provisional use in response to the pandemic. A formal approval requires more comprehensive data and regulatory review.

As for Canada, Prime Minister Justin Trudeau has said he expects 249,000 doses of the Pfizer-BioNTech vaccine to be on hand by the end of the year. Other vaccines, such as one produced by Moderna, are also under review by Canadian health authorities, who said at a news conference Wednesday that they expect to issue further decisions on those soon.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Colin Dwyer covers breaking news for NPR. He reports on a wide array of subjects — from politics in Latin America and the Middle East, to the latest developments in sports and scientific research.
More News
Support nonprofit, public service journalism you trust. Give now.